|

REDUCE LAP-HF III Corvia Protocol 1701

RECRUITINGSponsored by Corvia Medical
Actively Recruiting
SponsorCorvia Medical
Started2017-07-12
Est. completion2026-07-31
Eligibility
Age40 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03191656

Summary

This is a post market trial to be conducted at sites in Germany. The device has CE approval in the EU. The purpose of this observational registry is to collect post market data in consecutive patients treated with the IASD System II, to further evaluate efficacy, safety and quality of life outcomes as a new treatment for patients with heart failure in a "real world" practice setting.

Eligibility

Age: 40 Years+Healthy volunteers accepted
This is a post market registry so no criteria requirements (only recommendations).

Conditions2

Heart DiseaseHeart Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.